about
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. ...
Read More
6.37
-1.38
(-17.81%)
119.9K
XNAS Volume
High volume+loss today
XNAS 14 Jan, 2026 2:14 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
MetaVia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..